These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10083400)

  • 1. The role of cytokines in rejection of discordant xenotransplants.
    Saadi S; Takahashi T; Nagayasu T; Holzknecht RA; Platt JL
    Transplant Proc; 1999; 31(1-2):911-2. PubMed ID: 10083400
    [No Abstract]   [Full Text] [Related]  

  • 2. Xenotransplantation: endothelial cell activation and beyond.
    Bach FH; Robson SC; Ferran C; Millan M; Anrather J; Kopp C; Lesnikoski B; Goodman DJ; Hancock WW; Wrighton C
    Transplant Proc; 1995 Feb; 27(1):77-9. PubMed ID: 7879178
    [No Abstract]   [Full Text] [Related]  

  • 3. Endothelial cell activation and thromboregulation during xenograft rejection.
    Bach FH; Robson SC; Ferran C; Winkler H; Millan MT; Stuhlmeier KM; Vanhove B; Blakely ML; van der Werf WJ; Hofer E; de Martin R; Hancock WW
    Immunol Rev; 1994 Oct; 141():5-30. PubMed ID: 7868157
    [No Abstract]   [Full Text] [Related]  

  • 4. Discordant xenografting: a summary and look to the future.
    Bach FH
    Transplant Proc; 1992 Apr; 24(2):739-42. PubMed ID: 1566503
    [No Abstract]   [Full Text] [Related]  

  • 5. Humoral rejection and endothelial cell activation, 2001.
    Saadi S; Platt JL
    Xenotransplantation; 2002 Jul; 9(4):239-41. PubMed ID: 12060459
    [No Abstract]   [Full Text] [Related]  

  • 6. Hyperacute rejection of renal discordant xenograft (pig-to-rabbit): model assessment and rejection mechanisms.
    Marino IR; Ferla G; Celli S; Stieber A; Muttillo I; Maggiano N; Mazzaferro V; Perrelli L; Musiani P
    Transplant Proc; 1990 Jun; 22(3):1071-6. PubMed ID: 2190372
    [No Abstract]   [Full Text] [Related]  

  • 7. A synthetic dextran derivative inhibits complement activation and complement-mediated cytotoxicity in an in vitro model of hyperacute xenograft rejection.
    Thomas H; Maillet F; Letourneur D; Jozefonvicz J; Kazatchkine MD; Fischer E
    Transplant Proc; 1996 Apr; 28(2):593-4. PubMed ID: 8623290
    [No Abstract]   [Full Text] [Related]  

  • 8. Immunobiology of xenotransplantation.
    Platt JL
    Transpl Int; 2000; 13 Suppl 1():S7-10. PubMed ID: 11111952
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endothelial and host mononuclear cell activation and cytokine expression during rejection of pig-to-baboon discordant xenografts.
    Lesnikoski BA; Shaffer DA; Van der Werf WJ; Dalmasso AP; Soares MP; Latinne D; Bazin H; Hancock WW; Bach FH
    Transplant Proc; 1995 Feb; 27(1):290-1. PubMed ID: 7879007
    [No Abstract]   [Full Text] [Related]  

  • 10. Molecular barriers to xenotransplantation.
    Lawson JH; Platt JL
    Transplantation; 1996 Aug; 62(3):303-10. PubMed ID: 8779674
    [No Abstract]   [Full Text] [Related]  

  • 11. Attempts to prepare suitable complement regulatory molecules for clinical xenotransplantation.
    Miyagawa S; Matsunami K; Yoshitatsu M; Mikata S; Matsuda H; Shirakura R
    J Card Surg; 2001; 16(6):429-38. PubMed ID: 11925023
    [No Abstract]   [Full Text] [Related]  

  • 12. Profound pulmonary hypertension characteristic of pig lung rejection by human blood is mediated by xenoreactive antibody independent of complement.
    Pierson RN; Kaspar-König W; Tew DN; Young VK; Braidley PC; White DJ; Wallwork J
    Transplant Proc; 1995 Feb; 27(1):274. PubMed ID: 7879001
    [No Abstract]   [Full Text] [Related]  

  • 13. Prevention of complement-mediated activation of xenogeneic endothelial cells in an in vitro model of xenograft hyperacute rejection by C1 inhibitor.
    Dalmasso AP; Platt JL
    Transplantation; 1993 Nov; 56(5):1171-6. PubMed ID: 8249120
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ancient proteins and futuristic surgery: the role of complement in discordant xenograft rejection.
    Winkler M
    Transplant Proc; 2001; 33(7-8):3862-4. PubMed ID: 11750645
    [No Abstract]   [Full Text] [Related]  

  • 15. Prevention of hyperacute xenograft rejection by intravenous immunoglobulin in the pig-to-human combination.
    Gautreau C; Cardoso J; Woimant G; Zhao Z; Chereau C; Cherruau B; Vandeginste N; Devillier P; Houssin D
    Transplant Proc; 1994 Jun; 26(3):1281. PubMed ID: 8029908
    [No Abstract]   [Full Text] [Related]  

  • 16. Immunobiology of discordant xenograft rejection and potential therapeutic modalities.
    Robson SC; Candinas D; Winkler H; Kopp C; Hancock WW; Bach FH
    Transplant Proc; 1996 Jun; 28(3):1154-5. PubMed ID: 8658607
    [No Abstract]   [Full Text] [Related]  

  • 17. Prolonged survival of discordant xenografts in a subset of complement-depleted nude rats.
    Fryer JP; Chen S; Johnson EM; Simone P; Sun LH; Goswitz JJ; Matas AJ
    Transplant Proc; 1996 Apr; 28(2):700. PubMed ID: 8623353
    [No Abstract]   [Full Text] [Related]  

  • 18. Apoptosis in acute vascular rejection of xenografts.
    Holzknecht ZE; Williams JM; Plummer TB; Platt JL
    Transplant Proc; 2000 Aug; 32(5):973. PubMed ID: 10936305
    [No Abstract]   [Full Text] [Related]  

  • 19. The role of antiendothelial antibody in primate cardiac xenograft rejection.
    O'Hair DP; McManus RP; Johnson CP; Scott JP
    Transplant Proc; 1992 Apr; 24(2):506-7. PubMed ID: 1566407
    [No Abstract]   [Full Text] [Related]  

  • 20. Natural IgM play a major role in hyperacute rejection of discordant heart xenografts.
    Gambiez L; Salamé E; Chéreau C; Calmus Y; Ayani E; Houssin D; Weill B
    Transplant Proc; 1992 Apr; 24(2):441-2. PubMed ID: 1566380
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.